Connect Biopharma Holdings Limited
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.About CNTB
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.
CEOBarry D. Quart
CEOBarry D. Quart
Employees62
Employees62
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees62
Employees62
CNTB Key Statistics
Market cap140.88M
Market cap140.88M
Price-Earnings ratio-8.98
Price-Earnings ratio-8.98
Dividend yield—
Dividend yield—
Average volume573.84K
Average volume573.84K
High today—
High today—
Low today—
Low today—
Open price$2.65
Open price$2.65
Volume0.00
Volume0.00
52 Week high$3.28
52 Week high$3.28
52 Week low$0.51
52 Week low$0.51
Stock Snapshot
As of today, Connect Biopharma Holdings Limited(CNTB) shares are valued at $2.54. The company's market cap stands at 140.88M, with a P/E ratio of -8.98.
On 2025-12-05, Connect Biopharma Holdings Limited(CNTB) shares started trading at $2.65, with intraday highs of — and lows of —.
Trading volume for Connect Biopharma Holdings Limited(CNTB) stock has reached 0, versus its average volume of 573.84K.
The stock's 52-week range extends from a low of $0.51 to a high of $3.28.
The stock's 52-week range extends from a low of $0.51 to a high of $3.28.
People also own
Based on the portfolios of people who own CNTB. This list is generated using Robinhood data, and it’s not a recommendation.